Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT).
Iftikhar R, Ahmad P, de Latour R, Dufour C, Risitano A, Chaudhri N, Bazarbachi A, De La Fuente J, Höchsmann B, Osman Ahmed S, Gergis U, Elhaddad A, Halkes C, Albeirouti B, Alotaibi S, Kulasekararaj A, Alzahrani H, Ben Othman T, Cesaro S, Alahmari A, Rihani R, Alshemmari S, Hamidieh AA, Bekadja MA, Passweg J, Al-Khabori M, Rasheed W, Bacigalupo A, Chaudhry QU, Ljungman P, Marsh J, El Fakih R, Aljurf M; Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT). Iftikhar R, et al. Among authors: alzahrani h. Bone Marrow Transplant. 2021 Oct;56(10):2518-2532. doi: 10.1038/s41409-021-01332-8. Epub 2021 May 19. Bone Marrow Transplant. 2021. PMID: 34011966 Review.
Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone.
Al Beihany A, Al Omar H, Sahovic E, Chaudhri N, Al Mohareb F, Al Sharif F, Al Zahrani H, Al Shanqeeti A, Seth P, Zaidi S, Morshed M, Al Anazi K, Mohamed G, Gyger M, Aljurf M. Al Beihany A, et al. Bone Marrow Transplant. 2008 Feb;41(3):287-91. doi: 10.1038/sj.bmt.1705896. Epub 2007 Nov 5. Bone Marrow Transplant. 2008. PMID: 17982501 Clinical Trial.
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
Aljurf M, Al Qurashi F, Al Mohareb F, Sahovic E, Al Sharif F, Al Zahrani H, Al Shanqeeti A, Owaidah T, Iqbal A, Zaidi SZ, Nurgat ZA, Sanz M, Chaudhri N. Aljurf M, et al. Med Oncol. 2010 Sep;27(3):702-7. doi: 10.1007/s12032-009-9272-2. Epub 2009 Aug 8. Med Oncol. 2010. PMID: 19669610 Clinical Trial.
Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).
Aljurf M, Zaidi SZ, Hussain F, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mahmoud HK, Haddad A, Adil S, Ben Othman T, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Ayas M, Al Zahrani H, Al Mohareb F, El Solh H. Aljurf M, et al. Transfus Apher Sci. 2010 Apr;42(2):169-75. doi: 10.1016/j.transci.2010.01.012. Epub 2010 Jan 27. Transfus Apher Sci. 2010. PMID: 20110194
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Al-Zahrani H, Nassar A, Al-Mohareb F, Al-Sharif F, Mohamed S, Al-Anazi K, Patel M, Rasheed W, Saleh AJ, Bakr M, Ahmed S, Ibrahim K, Hussain F, Elkum N, Elhassan T, Nurgat Z, Chaudhri N, Aljurf M. Al-Zahrani H, et al. Biol Blood Marrow Transplant. 2011 May;17(5):717-22. doi: 10.1016/j.bbmt.2010.08.013. Epub 2010 Aug 22. Biol Blood Marrow Transplant. 2011. PMID: 20736079 Free article.
High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection.
Saleh AJ, Al Mohareb F, Al Rabiah F, Chaudhri N, Al Sharif F, Al Zahrani H, Mohamed SY, Patel M, Rasheed W, Nurgat Z, Bakr M, Ahmed S, Zaidi S, Nasser A, Ibrahim K, Al Abdely H, Aljurf M. Saleh AJ, et al. Hematol Oncol Stem Cell Ther. 2010;3(3):116-20. doi: 10.1016/s1658-3876(10)50021-9. Hematol Oncol Stem Cell Ther. 2010. PMID: 20890068 Free article. Clinical Trial.
365 results